Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 11/30/2015
Document Outline
Entire Document (2894.3 KB)
Subdocument 1 - 10-K - ANNUAL REPORT
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Page 4 - BUSINESS
Page 5 - Reportable Segments
Page 6 - illumi
Page 7 - Market Trends
Page 8 - North America
Page 9 - Helicobacter pylori
Page 10 - Women s Health STD
Page 11 - Manufacturing
Page 12 - Government Regulation
Page 13 - Medical Device Tax
Page 14 - Market Trends
Page 15 - Research and Development
Page 16 - Environmental
Page 17 - We may be unable to successfully integrate operations or to achieve expected cost savings from acqui
Page 18 - Changing Diagnostic Market Conditions
Page 19 - Revenues for our Life Science segment may be impacted by customer concentrations and buying patterns
Page 20 - We may face increased competition upon expiration of our H. pylori patents in 2016 and 2017.
Page 21 - Significant interruptions in production at our principal manufacturing facilities and/or third-party
Page 22 - Finished Products
Page 23 - If product liability lawsuits are successfully brought against us, we may incur substantial liabilit
Page 24 - Breaches of our information technology systems could have a material adverse effect on our operation
Page 25 - Risks Related to Our Common Stock
Page 26 - LEGAL PROCEEDINGS
Page 27 - SELECTED FINANCIAL DATA
Page 28 - Fiscal Year
Page 29 - Revenue Overview- By Product Platform/Type
Page 30 - Diagnostics Products
Page 31 - Immunoassay Products
Page 32 - Diagnostics Revenue Overview- By Disease Family
Page 33 - Respiratory Products
Page 34 - Significant Customers
Page 35 - Operating Expenses:
Page 36 - General Administrative
Page 37 - Operating Income
Page 38 - Impact of Inflation
Page 39 - Capital Resources
Page 40 - Known Contractual Obligations:
Page 41 - Concentration of Customers/Products Risk
Page 42 - illumi
Page 43 - Intangible Assets
Page 44 - Recent Accounting Pronouncements:
Page 45 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Page 46 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 47 - Management s Report on Internal Control over Financial Reporting
Page 48 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 49 - N/A
Page 50 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 51 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollars in thousands)
Page 52 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in thousands)
Page 53 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 54 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 55 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollars and shares in thousands, except per share da
Page 56 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 57 - N/A
Page 58 - illumi
Page 59 - illumi
Page 60 - illumi
Page 61 - N/A
Page 62 - N/A
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - illumi
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Page 75 - EQUITY COMPENSATION PLAN INFORMATION
Page 76 - EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 77 - N/A
Page 78 - N/A
Page 79 - N/A
Page 80 - Year Ended September 30, 2015:
Subdocument 2 - EX-10.8 - EX-10.8
Page 1 - Exhibit 10.8
Page 2 - FY 2016 Published Net Earnings Guidance Range Diluted EPS of $******
Page 3 - Calculation
Subdocument 3 - EX-10.11 - EX-10.11
Page 1 - Exhibit 10.11
Page 2 - 3. Forfeiture of Restricted Units.
Page 3 - 6. Voting and Other Rights.
Page 4 - 15. Section 409A of the Code.
Page 5 - 21. Language.
Subdocument 4 - EX-10.12 - EX-10.12
Page 1 - Exhibit 10.12
Page 2 - 3. Forfeiture of Restricted Units
Page 3 - seventh
Page 4 - 12. Adjustments
Page 5 - 20. Governing Law
Subdocument 5 - EX-13 - EX-13
Page 1 - Exhibit 13
Page 2 - CORPORATE PROFILE
Page 3 - Corporate Data
Page 4 - PERFORMANCE GRAPH
Subdocument 6 - EX-21 - EX-21
Page 1 - Exhibit 21
Subdocument 7 - EX-23 - EX-23
Page 1 - Exhibit 23
Subdocument 8 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 9 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 10 - EX-32 - EX-32
Page 1 - Exhibit 32
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer